$MRVL

Koopmans Chris sold $1.8M of MRVL (indirect holdings)

Koopmans Chris (President and COO) sold 10,000 indirectly-held shares of Marvell Technology, Inc. (MRVL) at $180.50 ($1.80M total) on 2026-08-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Koopmans Chris
Published Aug 3, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 6:16 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$MRVL
Neutral
high confidence
Mentioned
$MRVL
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MRVLNeutralLow
01

Why it matters

The disclosure updates the insider’s holdings but does not introduce new guidance, contracts, litigation, or regulatory developments.

02

Market read

Traders may note the insider sale for sentiment, but it is unlikely to change Marvell’s fundamental outlook.

03

What to watch

The sale is indirect and pre-arranged; without additional context (e.g., other concurrent insider buys/sales), the signal-to-noise for price impact is low.

Relevance 5/10Novelty 3/10Timing: filed 2026-08-03 (same day as transaction)

Background

The article is an SEC Form 4 insider transaction disclosure for Marvell Technology, Inc.

Company-level read

Ticker impact

$MRVLNeutralHigh confidence
Context

Marvell Form 4 shows COO Chris Koopmans sold 10,000 shares at $180.50 on 2026-08-03 under a pre-arranged 10b5-1 plan.

Expected impact

Likely minimal near-term impact; any effect is more about signaling than fundamentals.

Evidence & confidence

The filing is a Form 4 insider transaction with an explicit 10b5-1 pre-arranged plan, and it provides no new company-specific business information.

Market effects

No clear sector read-through; insider sales under 10b5-1 are generally not informative for semiconductor fundamentals.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can coincide with private views on valuation or liquidity needs, which some traders may front-run.

Key entities

  • Marvell Technology, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Koopmans Chris

    President and COO who sold shares under a pre-arranged 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$MRVLMed

Should You Sell Your Marvell Stock Now That Higher Forecasts Are Not Enough?

Marvell Technology (MRVL) raised its revenue outlook to $18B for fiscal 2028, but its stock fell 16.4% over three months. The company trades at a P/E of 88.0, significantly higher than the S&P 500's 22.5. Management expects revenue growth of about 50% in fiscal 2028, with major gains from an AI chip deal anticipated in fiscal 2029 and beyond.

$MRVLMed

Marvell Technology (MRVL) Shares Skyrocket, What You Need To Know

Marvell Technology (MRVL) shares rose 6.1% after announcing 2nm optical interconnect demonstrations for AI data centers. Morgan Stanley raised its price target to $268. Shares closed at $257.14, up 5.5%. The company is up 187% YTD but 19% below its 52-week high. Positive macroeconomic factors and sector-wide AI chipmaker rally contributed to the surge.

$MRVLMed

Why Marvell Stock Rallied Today

Marvell Technology (MRVL) shares rose 6% on Monday after announcing a 2nm optical interconnect demo for AI data centers. Morgan Stanley raised its price target to $268, citing potential $40B+ fiscal 2030 revenue. MRVL grew revenue 42% to $8.2B in fiscal 2026, forecasting 45% and 50% growth for fiscal 2027 and 2028, respectively.